Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
648 hedge funds and large institutions have $12B invested in Exact Sciences in 2023 Q4 according to their latest regulatory filings, with 97 funds opening new positions, 217 increasing their positions, 221 reducing their positions, and 67 closing their positions.
45% more first-time investments, than exits
New positions opened: 97 | Existing positions closed: 67
20% more call options, than puts
Call options by funds: $177M | Put options by funds: $147M
7% more capital invested
Capital invested by funds: $11.2B → $12B (+$832M)
4% more funds holding
Funds holding: 625 → 648 (+23)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
0.6% less ownership
Funds ownership: 90.42% → 89.82% (-0.6%)
2% less repeat investments, than reductions
Existing positions increased: 217 | Existing positions reduced: 221
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$87.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$68.4M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$60.4M |
| 4 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$53.8M |
| 5 |
Jennison Associates
New York
|
+$43.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$141M |
| 2 |
JP Morgan Chase
New York
|
-$105M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$51.4M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$49.7M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$48.2M |
EXAS Hedge Fund Activity: Q4 2023 in Review
648 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2023, worth a combined $12B — up 7.4% from $11.2B a quarter earlier.
Buyers outnumbered sellers: 97 funds opened new EXAS positions and 67 closed out — a net gain of 30 holders — while 217 added to existing stakes and 221 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $87.4M. The largest seller was Fidelity Investments, cutting an estimated $141M.
- 648 institutional investors held Exact Sciences (EXAS) as of Q4 2023, up from 625 in Q3 2023.
- Funds reported $12B of Exact Sciences stock for Q4 2023, up 7.4% quarter-over-quarter.
- 97 funds opened new Exact Sciences positions in Q4 2023 and 67 closed out, a net change of +30 holders.
- The largest Exact Sciences buyer in Q4 2023 was Morgan Stanley, an estimated $87.4M added.
- The largest Exact Sciences seller in Q4 2023 was Fidelity Investments, an estimated $141M sold.
Based on aggregated 13F filings for Q4 2023.